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Abstract An integrated approach in protein discovery through
the use of multidisciplinary tools was reported. A novel protein,
Hcc-1, was identified by analysis of the hepatocellular carcinoma
(HCC)-M cell proteome. The assembled EST sequence of the
210 amino acid novel protein was subsequently confirmed by
rapid amplification of cDNA ends (RACE). A total of 687 bp at
the 5P untranslated region of Hcc-1 was identified. Promoter
activity and several upstream open reading frames (uORFs) were
demonstrated at this region. Bioinformatics prediction showed
that the first 42 amino acids of the protein is a SAP domain with
sequence matches to hnRNP from various vertebrate species. The
Hcc-1 protein was localized to the cell nucleus while the gene was
localized to chromosome 7q22.1. Hcc-1 cDNA level was
increased in pancreatic adenocarcinoma. The level was also
increased in well-differentiated hepatocellular carcinoma but
decreases as the carcinoma progressed to a poorly differentiated
stage. ß 2001 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
Hepatocellular carcinoma (HCC) is a major type of primary
liver cancer. It originated from liver parenchymal cells (hepa-
tocytes) and is one of the major malignant diseases of the
world [1]. HCC is responsible for approximately one million
deaths per year, mainly in Asia and Africa [2]. Data from
epidemiology and experiments have identi¢ed several major
risk factors associated with HCC including chronic infection
with hepatitis B and hepatitis C viruses, and exposure to my-
cotoxins (a£atoxin B1) [3]. Recent advances in molecular ge-
netics have generated much interest in the role of cellular
oncogenes and the many oncogenic pathways leading to the
malignant transformation of liver cells [4]. Treatment of HCC
is largely palliative, and long-term survival is rare. As such,
HCC remains one of the most challenging areas of study in
medical oncology.
The reductionist approaches of the 20th century have suc-
cessfully generated information about individual cellular com-
ponents and their functions. However, an integrative analysis
of the function of multiple gene products has become a critical
issue for the future development in biology [5]. The advent of
high-throughput techniques, such as genomics and proteo-
mics, is enabling biologists to study cells as systems and to
analyze globally the interplay between gene expression, pro-
tein levels, pathways and activity. This comprehensive ap-
proach is an extremely powerful tool for studying changes
in gene expression and the resulting metabolic and phenotypic
e¡ects over the course of disease development [6].
Such global approach has not been widely applied in HCC
studies. An earlier study on HCC using the proteomics ap-
proach was to analyze the global expression of nuclear matrix
proteins [7]. Our group is currently looking at the develop-
ment of HCC by taking global proteome snapshots of the
human liver during di¡erent stages of disease progression.
We have generated a database of the HCC-M cell proteome
[8] recently. The large collection of proteins will facilitate pro-
teomic strategies to uncover protein interaction networks [9].
We anticipate that the HCC-M database will be a source for
the HCC research community and will foster the collaborative
and consortial interactions necessary for global approaches to
important biological questions.
In this paper, we demonstrated an integrative approach in
protein discovery. A novel protein, Hcc-1, was ¢rst discovered
by two-dimensional gel electrophoresis (2DE) and mass spec-
trometry (MS) analysis of HCC-M cells proteome. This was
followed by de novo peptide sequencing of selected peptides
using the tandem MS. Bioinformatics tools were subsequently
used in predictions and expressed sequence tag (EST) assem-
bly of a full-length in silico protein. Finally, a preliminary
characterization of the novel protein or gene was carried
out through an arsenal of molecular biology techniques.
2. Materials and methods
2.1. Proteome analysis and in silico protein assembly
The detailed procedure for proteome analysis of the HCC-M [10]
cell line by 2DE and matrix-assisted laser desorption-time of £ight
(MALDI-TOF) MS has previously been published [8]. Selected pep-
tide fragments were subjected to de novo sequencing using a PE Sciex
OSTAR tandem hybrid quadrupole-TOF (QqTOF) MS system (Con-
cord) equipped with a nanoelectrospray ionization (nESI) source (Pro-
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tana). The amino acid sequences were then sent for BLAST EST
search. Batch Entrez (NCBI, NIH) was used to get a list of EST in
FASTA format before submission to Cap3 Assembly (TigemNET)
software for contigs searching. The contig that contained the peptide
sequences in the appropriate open reading frame (ORF) was used to
check for possible sequence extension with other contigs obtained
from other peptide sequences. The sequence extension exercise was
reiterated until the largest possible open reading frame was found.
The assembled putative protein sequence was double-checked by com-
paring a theoretical trypsin digestion of the protein with the generated
protein peak list of the peptide mass ¢ngerprints to ensure that all
signi¢cant peaks were identi¢ed and the range of listed peaks covered
the putative protein.
2.2. Structure and function prediction for the novel protein
The putative structure and function of the novel protein Hcc-1 were
predicted using bioinformatics tools available from the internet. The
presence of trans-membrane segment and nuclear localization signal
was predicted using PredictProtein [11], mitochondrial targeting re-
gion using PSORT [12], and secretory signal using SignalP [13]. The
5P-untranslated segment of the gene was searched with ProScan [14]
for promoter region. Direct repeats in the gene were searched with
GCG Repeat (Wisconsin Package Version 10.0, Genetics Computer
Group (GCG), Madison, WI, USA).
Secondary structures of the protein were predicted by PHDsec [15].
The presence of domains in the protein was predicted by PredictPro-
tein coiled-coil prediction, low-complexity regions (SEG) [16] and
COILS [17]. The predicted domains were then used to search for
conserved domains by the reverse position-speci¢c (RPS)-BLAST
[18]. Sequence and domain homology searches were carried out with
position-speci¢c iterative (PSI)-BLAST on a non-redundant database
[18]. Hydropathicity of the protein was analyzed by the Kyte^Doo-
little plot [19].
2.3. Molecular characterizations of Hcc-1
The novel protein Hcc-1 was subjected to wet laboratory character-
izations to con¢rm its existence and its putative role in the cell. Unless
otherwise stated for experiments listed below, all DNA primers were
synthesized by Genset Singapore, restriction enzymes, dNTPs and
Taq polymerase were obtained from Promega, agarose from FMC
Bioproducts, polyacrylamide gel from Bio-Rad, and other chemical
reagents from Sigma. All polymerase chain reaction (PCR) ampli¢ca-
tions were carried out in a PTC-200 thermal cycler (MJ Research).
2.4. HCC-M RNA extraction and rapid ampli¢cation of cDNA ends
(RACE)
RNA was extracted from the HCC-M cells using the Trizol reagent
(Gibco). The extraction procedure was as recommended by the man-
ufacturer. The amount and purity of RNA extracted was measured by
absorbance reading at 260 and 280 nm. Typical total RNA yield from
3U107 cells is about 700 Wg and 260/280 ratio is 2.0.
RACE was performed using the SMART RACE cDNA ampli¢ca-
tion kit (Clontech). Gene-speci¢c primers for both the 5P and 3P
RACE were designed from EST sequences deduced from the peptide
fragments identi¢ed by tandem MS. The gene-speci¢c primers were
designed such that there would be a region of overlap between the
region to be ampli¢ed by 5P RACE and the region to be ampli¢ed by
3P RACE. The overlapping region permitted the use of the primers
together in a control PCR to eliminate non-speci¢c ampli¢cation. The
DNA sequences for the 5P and 3P RACE gene-speci¢c primers for
Hcc-1 are 5P-CTTTGCCTCTGTATCCTCTGTGGTTCC-3P and 5P-
TTCAATGTACCTGTGAGCTTGGAGAGTAAG-3P respectively.
RACE was performed with protocols from the kit manufacturer.
2.5. Chromosome walking
After the DNA sequence of the 5P RACE product was identi¢ed,
chromosome walking was performed to explore the 5P-untranslated
region of the Hcc-1 gene. Four libraries of uncloned, adaptor-ligated
genomic DNA fragments were purchased (GenomeWalker, Clontech).
Chromosome walking was performed by nested PCR on the four
libraries using primers designed from the 5P-end of the gene. The ¢rst
PCR was performed using an outer adaptor primer and a gene-spe-
ci¢c primer from the 5P-end of Hcc-1 (5P-CTTATGGAGCTC-
CACCGTCTCGGTC-3P). The PCR product was subjected to a sec-
ond PCR using an inner adaptor primer (located 3P to the outer
adaptor primer) and a gene-speci¢c primer located upstream of the
¢rst gene-speci¢c primer (5P-ATCTTGTTACCCCTCACTCCACT-
CCCC-3P). The nested PCR mixture and conditions were as recom-
mended by the kit manufacturer. PCR products were analyzed on a
1% agarose gel and sequenced (ABI377 automated DNA sequencer,
Applied Biosystems).
Genomic DNA from HCC-M cells was extracted using a DNA
extraction kit (Roche) and used to identify the genomic sequence of
the Hcc-1 gene. Gene-speci¢c primers were designed from the 5P-un-
translated region (5P-AGGGGTAACAAGATGGCGACCGAGAC-
3P) and 3P-untranslated region (5P-GTACCTGGGGTACATGCT-
CCCTCATTG-3P) of the gene. PCR was performed with 50 ng of
DNA, 0.2 WM each of the primers, 0.2 mM of dNTPs and AdvanTaq
Genomic DNA polymerase (Clontech) in a reaction bu¡er of the same
manufacturer. The cycling parameters were 94‡C for 30 s, 28 cycles of
94‡C for 30 s and 68‡C for 2 min, and a ¢nal extension at 68‡C for
5 min. The PCR product was examined by electrophoresis on a 1%
agarose gel and sequenced.
2.6. Hcc-1 promoter study
A promoter study was carried out to investigate whether the
5P-untranslated region of the Hcc-1 gene identi¢ed through chromo-
some walking contained any promoter function. The DNA from the
5P-untranslated region, identi¢ed through chromosome walking, was
cloned into the pSEAP2 vector containing a human secreted placental
alkaline phosphatase (SEAP) gene downstream from the cloning site
(Clontech). EcoRI restriction sites were generated on to the 5P-un-
translated region of the gene by PCR. The restricted fragment was
ligated into the pSEAP2 vector that was similarly restricted. The
clones were plated and selected by ampicillin resistance. The orienta-
tion of the inserted sequence was determined by DNA sequencing.
The pSEAP2 vectors containing either a SV40 early enhancer se-
quence downstream of the SEAP or a SV40 early promoter sequence
upstream of the SEAP were also constructed.
Successfully constructed vectors were transfected into Huh-7 cells
[20] by the SuperFect reagent method (Qiagen). Normalization and
measurement of transfection e⁄ciency were performed by co-trans-
fection with a pZeoSV2/lacZ vector (Invitrogen), which constitutively
expressed the LacZ gene for L-galactosidase assay. Average transfec-
tion e⁄ciency of 2% was routinely achieved at 24 h post-transfection.
All transfection experiments were performed in triplicate. Quantita-
tion of the SEAP was performed 48 h post-transfection using the
SEAP Fluorescent Detection kit (Clontech) with a £uorescence reader
(Spectra£uor, Tecan).
2.7. Chromosome localization of Hcc-1
The location of Hcc-1 on the chromosome was determined by ra-
diation hybrid (RH) panel screening. Two RH panels, Genebridge 4
and Stanford G3, were purchased (Research Genetics). DNA primers
£anking a region of 255 bp were generated from the 3P-untranslated
region of the gene. The sequences of the primers were 5P-TGAAAAA-
GAGGAAGGAGCGA-3P and 5P-TTCATGGATGTACCTGGGGT-
3P. DNA (25 ng) from each of the cell lines was used as PCR template
for the primers and each cell line was screened a minimum of two
times. Using standard PCR conditions and protocols, the ¢nished
reaction was assayed by electrophoresis on a 3% agarose gel. The
results were scored for the presence (score = 1) or absence (score = 0)
of a PCR product of the expected size. Results which were ambiguous
among the multiple runs were scored as a 2. These were then sub-
mitted to the Whitehead/MIT RH server (http://www-genome.wi.mit.
edu) for data generated from Genebridge 4, and to the Stanford
Human Genome Center RH server (http://shgc-www.stanford.edu)
for data from Stanford G3 panel, where it was tested against the
framework maps in the databases.
2.8. Hcc-1 recombinant protein expression
Full-length cDNA of Hcc-1 was generated by PCR from the HCC-
M total cDNA pool. The primers used were 5P-GGATCCAACAA-
GATGGCGACC-3P which contained a BamHI restriction site, and
5P-CAGCTGGTACCTGGGGTACAT-3P which contained a SalI re-
striction site. The ampli¢ed region spanned the entire expressed 630 bp
of the gene. PCR ampli¢cation was as described above. The PCR
product was analyzed by electrophoresis on a 2% agarose gel, puri¢ed,
restricted, and cloned into the pQE-30 expression vector (Qiagen).
The gene was cloned 3P to a 6UHis tag provided by the vector.
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The vector was transformed into Escherichia coli strain DH5K (Gib-
co). Expression and puri¢cation of the protein were done according to
the QiaExpressionist (Qiagen) protocol. The purity of the expressed
recombinant protein was examined by electrophoresis on a 10% so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and stained with Coomassie blue dye. The gel was also West-
ern blotted and the protein detected with anti-6UHis monoclonal
antibody (Qiagen). Quantitation of the expressed protein was per-
formed using the DC Protein Assay kit (Bio-Rad). The expressed
recombinant protein was con¢rmed by both N- and C-terminal se-
quencing.
2.9. Subcellular localization of Hcc-1
Polyclonal antibody against the Hcc-1 protein was raised in rabbits
as described [21]. Pre-immunized rabbit serum was collected as con-
trol. The speci¢city and sensitivity of the antiserum was determined by
Western blot analysis of HCC-M lysate after 2DE. It was also com-
pared to the anti-6UHis antibody in detecting the His-tagged re-
combinant protein in SDS^PAGE.
The subcellular localization of the Hcc-1 protein was determined by
immuno£uorescence staining [21] of HCC-M and Huh-7 cells with the
diluted (1:100) antiserum. Co-localization was performed with mouse
anti-human Golgi or mitochondria antibodies (LabVision). The anti-
serum was detected with diluted (1:50) £uorescein isothiocyanate
(FITC)-tagged sheep anti-rabbit antibody (Dako) while the anti-Golgi
or anti-mitochondria antibodies were detected with similarly diluted
rhodamine-tagged goat anti-mouse antibody (Dako). Images of the
cells were generated by overlaying the £uorescent microscopy (Zeiss
Laser Scanning Confocal Microscope 410) images of each dye togeth-
er with an image generated from the light microscopy using the same
microscope.
2.10. Hcc-1 cDNA distributions in tissues
The cDNA distribution of Hcc-1 gene in di¡erent tissues was per-
formed by PCR screening of commercially available multiple tissue
cDNA panels (Clontech) using the manufacturer’s protocol. The ex-
pression in four liver cell lines was also examined. The commercial
panels have been normalized using four housekeeping genes (K-tubu-
lin, L-actin, glyceraldehyde-3-phosphate dehydrogenase and phospho-
lipase A2). Paired liver samples, one from the hepatocellular carcino-
ma tissue and the other from the non-tumor part of the liver, were
obtained from informed consent subjects. All procedures with the
study subjects were in accordance with the Helsinki Declaration of
1975, as revised in 1983. The same pair of primers used for chromo-
some walking was used for detection of Hcc-1 cDNA. A region of
778 bp spanning from the 5P-untranslated region to the 3P-untrans-
lated region of the gene was covered. The PCR product (5 Wl) was
examined by electrophoresis on a 2% agarose gel. The experiment was
performed in duplicate to ensure reproducibility.
3. Results and discussions
We report the molecular cloning and initial characterization
of a novel nuclear protein discovered through concerted ef-
forts in proteomics and bioinformatics. The protein is one of
several novel proteins discovered in a proteomics initiative in
creating a database of expressed proteins in the HCC-M cell
line [8]. This discovery demonstrated an integrated approach
through combined disciplines in proteomics, bioinformatics
and functional genomics.
A protein spot which was not identi¢ed in SwissProt or
NCBI databases by peptide mass ¢ngerprinting from
MALDI-TOF data was subjected to de novo sequencing of
three of its in-gel trypsin-digested peptide fragments (Fig. 1).
The amino acid sequences from the fragments were then used
to search the EST database by using BLAST (tblastn). The
Cap3 Assembly (TigemNET) software was used to assemble
some 40 ESTs into a putative in silico ORF. Based on the
consensus DNA sequence derived from EST assembly, DNA
primers were designed from two of the peptide fragments (Fig.
2). RACE was performed to con¢rm the assembled putative
protein and to obtain more information on the 5P- and 3P-
untranslated regions of the gene. A total of 873 bp was iden-
ti¢ed. The RACE results were found to agree with the EST
assembled sequence of the protein. We named the protein
Hcc-1. The start codon of the gene was in agreement with
the Kozak consensus sequence for eukaryotic genes [22].
With the exception of the ¢rst 42 amino acids, Hcc-1 pro-
tein has no signi¢cant match in SwissProt or NCBI non-re-
dundant databases. Bioinformatics tools were not able to de-
termine the structure of Hcc-1. The current protein structure
prediction is usually done via homology modeling of known
Fig. 1. Peptide mass ¢ngerprint of Hcc-1 from MALDI-TOF analysis. Three peptide fragments (asterisked) were randomly chosen for de novo
sequencing using tandem MS. The amino acid sequences of the peptides were used for EST assembly into an in silico protein.
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protein structures with sequence homologies higher than 30%
[23]. Homology modeling could not be carried out as all the
sequences were having less than 30% homology with Hcc-1
and do not have any established structures. Even though pos-
sible secondary structures of Hcc-1 can be predicted using
software such as the PHD, we are unable to predict tertiary
structures of the protein.
The protein was found to have no predicted trans-mem-
brane segment (PredictProtein), no mitochondrial targeting
sequence (PSORT), and no secretory signal (SignalP). It was
also predicted to be a globular protein with predominantly
K-helix secondary structure (PHDsec). The protein may have
three domains based from searches using PredictProtein
(coiled-coil region at amino acid positions 30^51 and 146^
160), COILS (at amino acid positions 25^64 and 145^172),
and SEG low-complexity region (at amino acids 42^79 and
165^179). The novel protein was then divided into three do-
mains for subsequent searches.
The ¢rst domain (consisting of the ¢rst 42 amino acids) was
searched with the Conserved Domain database using RPS-
BLAST. The domain was found to have homology with the
SAP domain (e value: 5e-04), which is a putative bi-helical
DNA binding motif predicted to be involved in chromosomal
organization and transcriptional regulations [24]. The SAP
(after SAF-A/B, ACINUS and PIAS) motif is found in di-
verse nuclear proteins. SAF-A/B or heterogeneous nuclear
ribonucleoprotein U (sca¡old attachment factor A/B) binds
RNA through RGG box [25] and cleavage of the protein by
enzyme caspase-3 will result in apoptosis [26]. ACINUS or
apoptotic chromatin condensation inducer in the nucleus is
a caspase-3-activated protein required for apoptotic chroma-
tin condensation [27]. PIAS are protein inhibitors of activated
STAT (signal transducer and activator of transcription).
STAT proteins are latent cytoplasmic transcription factors
that become activated in response to stimulation by various
cytokines [28]. PIAS have been identi¢ed as potentially im-
portant down-regulators of this pathway.
Using PSI-BLAST on non-redundant database, amino acid
sequence 1^42 of Hcc-1 was matched to vertebrate heteroge-
neous nuclear ribonucleoprotein (hnRNP) with identities
match of above 45%: hnRNP U sca¡old attachment factor
A (SAF-A) (Q00839) of Homo sapiens, hnRNP U protein
(X65488) of H. sapiens, hnRNP U (AF073992) of Mus mus-
culus, SP120 (D14048) (nuclear sca¡old protein that binds the
matrix attachment region DNA) of Rattus norvegicus, and
SAF A (AF068847) of Xenopus laevis. The other two domains
(amino acids 43^170 and 171^210) were not found to have
any known homologous domain.
Chromosome walking was carried out to determine the
5P-untranscribed region of the Hcc-1 gene. A total of 687 bp
upstream of the start codon ATG was determined (Fig. 2). A
number of mini-cistrons or upstream open reading frames
(uORFs) were noted. The 5P-untranslated region of Hcc-1
gene was found to have a number of start and stop codons.
Fig. 2. The complete Hcc-1 gene (AJ409089). Underlined fragments
are amino acid sequences obtained by tandem MS analysis. Primers
used for RACE are highlighted in bold. Extra bases from EST as-
sembly are in lowercase. The translated product has 210 amino
acids (in single-letter code). Boxed sequences are the direct repeats
at both ends of the gene. Dotted sequences are uORFs before the
start of the Hcc-1 coding region. A total of 687 nucleotides were
identi¢ed at the 5P-untranslated region. Sequence with wavy line is
the 246 nucleotides used in promoter study to circumvent the
uORFs.
Fig. 3. Promoter study on the 5P-untranslated region of the Hcc-1
gene. The activity of the whole fragment (687 bp) was compared to
a shorter 246 bp fragment located at the 5P-portion of the untrans-
lated region. pSEAP2-Basic: the basic pSEAP2 vector; pSEAP2-
Positive Control: a control pSEAP2 vector with a SV40 promoter
upstream, and a SV40 enhancer downstream, of the SEAP gene;
pSEAP2-Pro: a pSEAP2 vector with the SV40 promoter upstream
of the multiple cloning site; pSEAP2-Enh: a pSEAP2 vector with
the SV40 enhancer downstream of the SEAP gene.
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The occurrence of a long 5P-untranslated region with mini-
cistrons or uORFs is not uncommon. It is found in a number
of proto-oncogenes and growth factors [29]. It is a structure
used in transcriptional regulation and translational control of
genes whose products are important for cell growth [30,31].
Chromosome walking into the Hcc-1 gene revealed no in-
tron. The ampli¢ed genomic DNA product was sequenced
and con¢rmed to have the same sequence with the expressed
cDNA of Hcc-1. Direct repeats of eight nucleotides long were
detected at the 5P- and 3P-untranslated regions of the gene
(Fig. 2). A processed mRNA can sometimes re-integrate
back into the genome and expressed on occasions. Processed
genes that are re-expressed as mRNA are sometimes called
retrogenes [32]. Several common characteristics of a retrogene
are lack of intron, direct eight nucleotides repeats, and retain-
ing the functionality and ORF of their parental gene [33,34].
Except from ¢nding a parental gene with introns, the Hcc-1
gene satis¢ed most criteria as a retrogene.
Promoter region was predicted from nucleotides 294^544 at
the 5P-untranslated region of the gene by ProScan (Fig. 2).
The prediction was based on regions of DNA that contain a
signi¢cant number and type of transcriptional elements that
are usually associated with eukaryotic polymerase II promoter
sequences. No TATA box and transcriptional start site were
predicted.
To con¢rm the bioinformatics prediction, the 687 bp frag-
ment was cloned into the pSEAP2 vector upstream of the
SEAP gene. The amount of the expressed SEAP was assayed
48 h post-transfection of the vector into Huh-7 cells. This
provided an indirect measurement of the strength of the pro-
moter activity of the gene. Low promoter activity was ob-
served (10 ng SEAP expressed per 5 Wg DNA) with the 687
bp fragment (Fig. 3). For the pSEAP2 vector construct with a
SV40 early promoter, an increase in SEAP transcription was
observed (90 ng SEAP expressed). However, high transcrip-
tion activity was obtained when the 687 bp fragment was
constructed into a vector containing SV40 early enhancer se-
quence (190 ng SEAP expressed). This showed that an en-
hancer element is needed for the transcriptional activity of
the promoter.
Fig. 4. A: Silver stained 2D gel image of HCC-M total lysate.
B: Western blot detection of Hcc-1 in HCC-M 2D gel. Western
blot determination of the sensitivity and speci¢city of the rabbit-
raised polyclonal antibody against Hcc-1. 2DE was carried out in
duplicate with HCC-M total protein lysate loaded at 40 g each.
One of the gels was silver stained (A) while another was used for
Western blot detection using the polyclonal antibody with calorimet-
ric detection (B). The location of the Hcc-1 protein was indicated
by an arrow.
Fig. 5. Upper panel: Huh-7 cells stained with anti-Hcc-1 (green)
and anti-Golgi (red) antibodies. Lower panel: HCC-M cells stained
with anti-Hcc-1 (green) and anti-mitochondria (red) antibodies. Sub-
cellular localization of the Hcc-1 protein in two liver cell lines. The
Hcc-1 antibody was detected with FITC labeled anti-rabbit anti-
body. Co-localization was performed with rhodamine labeled anti-
mouse antibodies against the Golgi (upper panel) and mitochondria
(lower panel).
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To circumvent the mini-cistrons, 246 bp (Fig. 2) from the
5P-end of the 687 bp fragment was ampli¢ed and inserted into
the pSEAP2 vector. No activity was observed when the
pSEAP2 vector was constructed without SV40 early enhancer
or promoter sequences. Transcriptional activity was observed
at half (110 ng of SEAP expressed) of that from 687 bp frag-
ment when the SV40 early enhancer sequence was included in
the construct (Fig. 3). The results showed that the promoter
region is located primarily at the middle of the identi¢ed 5P-
untranslated region of the gene. The enhancer sequence is
probably further upstream from the 687 bp sequence.
The placement of the Hcc-1 gene was the best possible when
scored against the framework markers at the time of writing.
The gene was assigned to chromosome 7 at position 7q22.1,
or 3.36 cR from a framework microsatellite marker, D75651
(GDB accession: AFM249za5). A search in the Mitelman
Database of Chromosome Aberrations in Cancer from the
National Cancer Center [35] revealed that there were no chro-
mosome aberrations (insertions, deletions, translocations, etc.)
reported for pancreatic tumors. There have been several re-
ported cases of hepatic adenocarcinomas associated with aber-
rations in chromosomes 1, 8, 14 and 16, hepatoblastoma is
associated with chromosomes 1, 4 and 8, and mesenchymal
tumor of the liver with chromosomes 11 and 19. A search in
the above database also shown that chromosome 7q22 is an
area implicated in a large number of human tumors (e.g. non-
Hogkins lymphoma, acute myeloid leukemia, germ cell tu-
mor). It is yet to be determined whether Hcc-1 plays a role
in chromosome aberrations leading to carcinoma.
The speci¢city and sensitivity of the rabbit-raised polyclonal
antibody against Hcc-1 was tested by Western blot analysis
after HCC-M 2DE. Two similar 2D gels of HCC-M were
created; each loaded with 40 Wg of total protein lysate. One
of the gels was silver stained (Fig. 4A), and the other Western
blotted. The polyclonal antibody at 1000Udilution was able
to detect the presence of the Hcc-1 protein in a colorimetric
assay with minimal non-speci¢city (Fig. 4B). The antibody
was then used in subcellular localization experiments whereby
Hcc-1 was found to localize to the nucleus of liver cells (Fig.
5). PredictProtein further supported the possibility of a nu-
clear protein with the prediction of a nuclear localization sig-
nal at amino acid positions 197^203.
The Hcc-1 protein migrated consistently at 35 kDa in 2DE
of the HCC-M lysate despite that the protein has only 210
amino acids with a theoretical molecular mass of 24 kDa (Fig.
4B). The theoretical molecular mass of the recombinant pro-
tein is 26 kDa due to 13 additional amino acids at the N-
terminal. The extra amino acids were the 6UHis tag and
amino acids from the multiple cloning site. The recombinant
Hcc-1 protein has also migrated as a 35 kDa band in SDS^
PAGE (results not shown). Both N- and C-terminal amino
acid sequencing results showed that the band at 35 kDa con-
tained the full-length Hcc-1 protein. The deviation in migra-
tion may be due to the fact that Hcc-1 is a very hydrophilic
Table 1
A semi-quantitative analysis of Hcc-1 cDNA levels in human tissues, liver cell lines and paired liver samples
Samples Hcc-1 cDNA levels
Healthy tissues colon 3
ovary 3
peripheral blood leukocyte 3
prostate +/3
small intestine 3
spleen +
testis ++
thymus +
brain 3
heart +
kidney +
liver +/3
lung 3
pancreas +
placenta 3
skeletal muscle 3
Diseased tissues breast carcinoma (GI-101) +/3
lung carcinoma (LX-1) 3
colon adenocarcinoma (CX-1) 3
lung carcinoma (GI-117) 3
prostatic adenocarcinoma (PC3) 3
colon adenocarcinoma (GI-112) 3
ovarian carcinoma (GI-102) 3
pancreatic adenocarcinoma (GI-103) +++
Liver cell lines HCC-M +
HepG2 +
Hep3B +
HuH4 +
HuH7 +
Paired liver samplesa non-tumor (subject A) 3
tumor (subject A) +++
non-tumor (subject B) ++
tumor (subject B) +
The semi-quantitative analysis was performed at 22 cycles of PCR. Saturation of PCR products began at 26 cycles. Expression level:
+++s++s+s+/3 ; 3, no expression.
aBoth subjects were positive for hepatitis B virus infection. Subject A had well-di¡erentiated tumor while subject B has poorly di¡erentiated tu-
mor.
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protein (with only 29.5% hydrophobic amino acids by Kyte^
Doolittle plot) that interferes with the SDS binding of the
protein in SDS^PAGE.
The PCR screening method was chosen over the conven-
tional Northern blot method because it permits detection of
mRNA of all abundance levels and it is much faster than
hybridization analyses. A trial PCR experiment was per-
formed at 20^32 cycles with two-cycle intervals. An aliquot
of the PCR mixture at each interval was electrophoresed on a
2% agarose gel. Exponential phase of the PCR was deter-
mined visually and found to range from 20 to 24 cycles. Sat-
uration was found to begin from cycle 26. We have chosen to
stop the PCR at cycle 22 for the semi-quantitative analysis of
Hcc-1 cDNA level in tissues.
The Hcc-1 cDNA distributions in various human tissues are
shown in Table 1. Experiments were performed in duplicate
and identical results were obtained. The Hcc-1 cDNA is found
at varying levels in several healthy tissues. The level is raised
markedly in the pancreatic adenocarcinoma tissue when com-
pared with healthy pancreas. Hcc-1 cDNA levels in the paired
liver samples are as tabulated (Table 1). Both subjects were
positive for hepatitis B virus infection. Subject A had well-
di¡erentiated tumor while subject B had poorly di¡erentiated
tumor. From the table, Hcc-1 seems to be di¡erentially ex-
pressed. It is increased in well-di¡erentiated hepatocellular
carcinoma but its level decreased as the tumor progressed to
poorly di¡erentiated hepatocellular carcinoma. The pancreas
and liver have the same embryonic developmental origin [36].
Thus it is not surprising to ¢nd the increase of Hcc-1 cDNA
in both types of tumor.
Expression of a human retrogene in several organs is not
common, though there are several reports on human retro-
genes having single organ expression [37]. Most retrogenes are
transcriptionally inactive and contain a number of mutations
that render them non-functional. However, there are some
reported functional retrogenes [33,34]. Hcc-1 is atypical as it
is expressed in several organs. Our non-saturating PCR on
normalized cDNA gives an accurate comparison of relative
mRNA copy numbers [38,39]. Hcc-1 cDNA is apparently
not expressed to high level except in pancreatic adenocarcino-
ma and hepatocellular carcinoma. Whether the translated
product has any biological activity remains to be determined.
During the course of this work, a human CD34+ stem cell
partial mRNA sequence was deposited with GenBank
(AF161434, February 2000). The sequence was found to
have 95.2% DNA sequence identity at the coding and 3P-un-
translated regions, and 70.2% amino acid sequence identity
with the Hcc-1 protein. We are reasonably convinced that
our sequence is authentic as it was obtained independently
through RACE and matched the assembled consensus EST
sequence derived from some 40 ESTs. Its existence was further
con¢rmed by chromosome localization using the 3P-untrans-
lated region, chromosome walking into both the coding se-
quence and the 5P-untranslated region, and demonstrated pro-
moter activity within the 5P-untranslated region. The minor
di¡erences between the two genes were probably caused by
inaccuracies in EST sequencing of the CD34+ stem cell cDNA
library. Another human pre-pro-B cell genomic clone
(AP001207, June 2000) from chromosome 8q23 was found
to have 53.3% DNA sequence identity with the Hcc-1 gene.
The region that has sequence identity with the Hcc-1 gene
occurred at 49^50 kb of the 154 kb genomic clone. The fact
that there were no suitable ORFs within that region of the
genomic clone and that Hcc-1 gene was localized to chromo-
some 7q22.1 showed that the Hcc-1 gene is a separate and
independent entity.
4. Conclusions
The bioinformatics predictions and experimental data sug-
gested that Hcc-1 is a nuclear protein with potential nucleic
acid binding capability that may participate in important
transcriptional or translational control of cell growth, metab-
olism, and possibly carcinogenesis. Further functional charac-
terizations are needed to fully understand the biology of the
novel nuclear protein and its roles in carcinogenesis. We are
currently in the process of ¢nding interacting partners for
Hcc-1 by protein^protein interaction study. A DNA protein
binding study will also be carried out to determine the ability
of Hcc-1 in binding RNA or DNA. It is hoped that a poten-
tial use of this gene product in the diagnosis or therapeutics of
an important class of tumors can be discovered in the near
future.
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